Media Release: Melbourne steps up to drive global health

Operations on 14 December, 2018

Images, video overlay, two case studies (rotavirus vaccine and TB in adolescents) and backgrounder available.

Melbourne Children’s Global Health initiative to take action for the:

  • Two million children dying annually from pneumonia and diarrhoea
  • 8 million new child and youth cases of TB each year
  • Mental health and wellbeing of youth caught up in global unemployment, civic unrest, conflict, urbanisation and migration
  • Hospitals and health workers who want training and education to help them save their young patients.

Three of Australia’s child health leaders are joining forces to tackle global child health. Melbourne Children’s Global Health will build on the achievements of the Murdoch Children’s Research Institute (MCRI), the Royal Children’s Hospital (RCH) and the University of Melbourne. Read More about Media Release: Melbourne steps up to drive global health

Case Study: New rotavirus vaccine enters manufacturing

Operations on 14 December, 2018

Bio Farma, Indonesia’s national vaccine company, is completing a phase 1 trial of a new rotavirus vaccine invented in Melbourne and has started pilot manufacture of the vaccine. Licencing trials are next, followed hopefully by release of the new vaccine in 2021.

The project is the culmination of a 42-year partnership between Melbourne and Gadjah Mada University which started after Ruth Bishop and colleagues found a virus, now known as rotavirus, in babies at the Royal Children’s Hospital in Melbourne. They showed it was the cause of an acute gastroenteritis that was hospitalising 10,000 Australian children every year and killing more than half a million children worldwide. Read More about Case Study: New rotavirus vaccine enters manufacturing